Postdural Puncture Headache
Conditions
Keywords
Sphenopalatine Ganglion Block, Postdural Puncture Headache
Brief summary
Background: Postdural puncture headache (PDPH), which is one of the complications of spinal anesthesia, is a condition that negatively affects the quality of life of patients, causes late mobilization and prolonged hospital stay. Sphenopalatine ganglion block (SGB) has created a minimally invasive, easy, and safe treatment alternative. Objective: Evaluating the effectiveness of topical SGB on PDPH treatment. Design: Retrospective observational study Setting: Single center tertiary level of care hospital study. The files of PDPH patients between Jan 2018 and Jan 2020 were scanned. Patients: PDPH patients aged 18-65 are included and any patients with primary/secondary headache history are excluded. Main outcome measures: Patients were divided into 2 groups. The group that given only conservative treatment was named as Group C, and the group of patients who had additionally been applied SGB was named as Group SGB. Headache severity was measured with Visual Analogue Scale (VAS) at the 1st,3rd, 12th and 24th hours of the treatment, in supine and upright position.
Interventions
OTHERConservative Treatment for Postdural Puncture Headache
The patients in Group C were given continuous bed rest in the supine position, 3000 mL daily hydration, 6 mg kg-1 aminophylline , 2 g day-1 paracetamol and 65 mg day-1 caffeine as conservative treatment. Topical SGB was applied to patients in Group SGB in addition to conservative treatment.
Sponsors
Sakarya University
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* 18-65 years-old * not having any headache diagnosis (G44 and subgroup according to the International Classification of Diseases-10 classification), * developed PDPH according to the International Headaches Classification after the neuraxial procedure
Exclusion criteria
* history of primary headaches such as migraine, cluster type, tension type * secondary headache such as preeclampsia / eclampsia, cerebral venous thrombosis, stroke, ruptured aneurysm, hypertensive encephalopathy, pituitary apoplexy, meningitis and subarachnoid hemorrhage * any local or systemic infection
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Headache in Supine Position | 1st, 3rd, 12th and 24th hours of follow-up | Headache severity changes with Visual Analogue Scale (VAS, 0-10, 0: no pain, 10:worst pain) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Headache in Prone Position | 1st, 3rd, 12th and 24th hours of follow-up | Headache severity changes with Visual Analogue Scale (VAS, 0-10, 0: no pain, 10:worst pain) |
| Successfully treated patients ratio | 24th hour of follow-up | At the 24th hour of their follow-up, all patients with a VAS\>3 (Visual Analogue Scale) headache in an upright position are considered as unsuccessful treatment and are directed to the epidural blood patch procedure. Both groups will be compared with successfully treated patients ratios. |
Countries
Turkey (Türkiye)
Outcome results
None listed